Professor Usha Menon
University College London
H-index: 85
Europe-United Kingdom
Top articles of Professor Usha Menon
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction | medRxiv | Kristia Yiangou Nasim Mavaddat Joe Dennis Maria Zanti Qin Wang | 2024 |
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials | Contemporary Clinical Trials | Matthew R Sydes Macey L Murray Saiam Ahmed Sophia Apostolidou Judith M Bliss | 2024/3/26 |
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk | medRxiv | Daniel R Barnes Jonathan P Tyrer Joe Dennis Goska Leslie Manjeet K Bolla | 2024 |
583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study | Samuel Oxley Jacqueline Sia Ashleigh Samuels Ashwin Kalra Xia Wei | 2024/3/1 | |
1341 Long-term evaluation of lynch syndrome endometrial surveillance: 16 year experience at a specialist centre | Malcolm Scott Ertan Saridogan Usha Menon Ranjit Manchanda Guldzhan Vorona | 2024/3/1 | |
Screening and prevention of ovarian cancer | Michail Sideris Usha Menon Ranjit Manchanda | 2024/2/14 | |
Trials Methodology Research: what is it and why should India invest in it? | Sangeetha Paramasivan Anant Bhan Rashmi Rodrigues Usha Menon | 2024/3/1 | |
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study | British journal of cancer | Ashley Weir Eun-Young Kang Nicola S Meagher Gregg S Nelson Prafull Ghatage | 2023/1/26 |
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study | The Journal of Pathology: Clinical Research | Martin Köbel Eun‐Young Kang Ashley Weir Peter F Rambau Cheng‐Han Lee | 2023/5 |
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel | Journal of medical genetics | Hagai Levi Shai Carmi Saharon Rosset Rinat Yerushalmi Aviad Zick | 2023/12/1 |
Plasma cell‐free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case‐control study and an ovarian cancer screening trial | International Journal of Cancer | Chiara Herzog Allison Jones Iona Evans Daniel Reisel Adeola Olaitan | 2023/10/20 |
Profiling the immune landscape in mucinous ovarian carcinoma | Gynecologic oncology | Nicola S Meagher Phineas Hamilton Katy Milne Shelby Thornton Bronwyn Harris | 2023/1/1 |
Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning | Communications Medicine | Nuno R Nené Alexander Ney Tatiana Nazarenko Oleg Blyuss Harvey E Johnston | 2023/1/20 |
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis | JNCI: Journal of the National Cancer Institute | Zhuxuan Fu Maria Mori Brooks Sarah Irvin Susan Jordan Katja KH Aben | 2023/5/1 |
Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? | Cancer Epidemiology, Biomarkers & Prevention | Lukas Owens Kemal Caglar Gogebakan Usha Menon Roman Gulati Noel S Weiss | 2023/6/1 |
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2 | Human mutation | Maria Zanti Denise G O'Mahony Michael T Parsons Hongyan Li Joe Dennis | 2023/9/14 |
Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection | medRxiv | Alexander Ney Nuno Rocha Nene Eva Sedlak Pilar Acedo Oleg Blyuss | 2023 |
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study | Cancer | Eun‐Young Kang Ashley Weir Nicola S Meagher Kyo Farrington Gregg S Nelson | 2023/3/1 |
Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India | D Pillai J Narayan A Gentry-Maharaj S Deo DK Vijaykumar | 2023 | |
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial | The Lancet Oncology | Usha Menon Aleksandra Gentry-Maharaj Matthew Burnell Andy Ryan Naveena Singh | 2023/9/1 |
Co-Authors
